The Effect of the Antioxidant Drug U-74389G on Albumin Levels during Ischemia Reperfusion Injury in Rats

1. https://www.caymanchem.com/app/template/Product.vm/catalog/75860.Search in Google Scholar

2. Fenglin Shi, Jennifer Cavitt, Kenneth L Audus. 21-aminosteroid and 2-(aminomethyl)chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radical Biology and Medicine, 19(3), 349-357 (1995).10.1016/0891-5849(95)00049-4Search in Google Scholar

3. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The effect of the antioxidant drug “U-74389G” on acid phosphatase levels during ischemia reperfusion injury in rats. Appl Med Res. 2016;2(1):1-5.10.5455/amr.20160224103746Search in Google Scholar

4. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The effect of the antioxidant drug “U-74389G” on white blood cells levels during hypoxia reoxygenation injury in rats. Asian Journal of Pharmacology and Toxicology. 2016;4(13): 22-32.Search in Google Scholar

5. Τsompos C, Panoulis C, Τοutouzas K, Ζografos G, Papalois A. Acute Effect Of The Antioxidant Drug “U-74389g” On Hematocrit Levels During Hypoxia and Reoxygenation Injury In Rats. Sci. Med. 2016;26(1): 15-21.Search in Google Scholar

6. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The acute effect of the antioxidant drug “U-74389G” on red blood cell distribution width levels during hypoxia reoxygenation injury in rats. Folia Medica Пловдив 2015;57(3&4):235-242.10.1515/folmed-2015-0044Search in Google Scholar

7. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos G, Papalois A. The antioxidant drug“U-74389G” attenuates the mean corpuscular hemoglobin concentration levels during hypoxia reoxygenation injury in rats. JIRMEPS, 9(4): 158-163, 2016Search in Google Scholar

8. Liepinsh E, Makrecka M, Kuka J, et al: The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism. 2013 Oct 17. pii: S0026-0495(13)00298-9.Search in Google Scholar

9. Abubakar S, Sabir A, Ndakotsu M, et al: Low admission serum albumin as prognostic determinant of 30-day case fatality and adverse functional outcome following acute ischemic stroke. Pan Afr Med J. 2013;14:53.Search in Google Scholar

10. Herisson F, Delaroche O, Auffray-Calvier E, et al: Ischemia-modifi ed albumin and heart fatty acidbinding protein: could early ischemic cardiac biomarkers be used in acute stroke management? J Stroke Cerebrovasc Dis. 2010 Jul-Aug;19(4):279-82.10.1016/j.jstrokecerebrovasdis.2009.07.004Search in Google Scholar

11. Consuegra-Sanchez L, Bouzas-Mosquera A, Sinha MK, et al: Ischemia-modifi ed albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels. 2008 May;23(3):174-80.10.1007/s00380-007-1031-8Search in Google Scholar

12. Polk JD, Rael LT, Craun ML, et al: Clinical utility of the cobalt-albumin binding assay in the diagnosis of intestinal ischemia. J Trauma. 2008 Jan;64(1):42-5.10.1097/TA.0b013e31815b846aSearch in Google Scholar

13. Dusek J, Tichý M, Stásek J, et al: Ischemia-modifi ed albumin: new marker of myocardial ischemia?. Cas Lek Cesk. 2005;144(5):295-7; discussion 297.Search in Google Scholar

14. Worster A, Devereaux PJ, Heels-Ansdell D, et al: Capability of ischemia-modifi ed albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ. 2005 Jun 21;172(13):1685-90.10.1503/cmaj.045194Search in Google Scholar

15. Rafael Sadaba J, Conroy JL, Burniston M, et al: Effect of radial artery harvesting on tissue perfusion and function of the hand. Cardiovasc Surg. 2001 Aug;9(4):378-82.10.1016/S0967-2109(00)00148-4Search in Google Scholar

16. Steinbauer M, Guba M, Büchner M, et al: Impact of polynitroxylated albumin (PNA) and tempol on ischemia/reperfusion injury: intravital microscopic study in the dorsal skinfold chamber of the Syrian golden hamster. Shock. 2000 Aug;14(2):163-8.10.1097/00024382-200014020-0001510947161Search in Google Scholar

17. Donaldson GC, Robinson D, Allaway SL. An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin Sci (Lond). 1997 Mar;92(3):261-8.10.1042/cs09202619093006Search in Google Scholar

18. Arend SM, Bax JJ, Hermans J, et al: The short-term effect of intravenous nitroglycerin on haematocrit; an additional benefit in patients with myocardial ischaemia? Eur Heart J. 1994 Jan;15(1):114-9.10.1093/oxfordjournals.eurheartj.a0603628174570Search in Google Scholar

19. Pollock DM, Opgenorth TJ. Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure. J Pharmacol Exp Ther. 1990 Dec;255(3):1166-9.Search in Google Scholar

20. Tilton RG, Cole PA, Zions JD, et al: Increased ischemia-reperfusion injury to the heart associated with short-term, diet-induced hypercholesterolemia in rabbits. Circ Res. 1987 Apr;60(4):551-9.10.1161/01.RES.60.4.551Search in Google Scholar

21. Bagetta G, Palma E, Piccirilli S, et al: Seizures and hippocampal damage produced by dendrotoxin- K in rats is prevented by the 21-aminosteroid U-74389G. Exp Neurol. 1997 Sep;147(1):204-10.10.1006/exnr.1997.65879294417Search in Google Scholar

22. Tasaka S, Ishizaka A, Urano T, et al: Attenuation of hyperoxic lung injury by the 21-aminosteroid U-74389G. J Appl Physiol (1985). 1995 May;78(5):1635-41.10.1152/jappl.1995.78.5.16357649897Search in Google Scholar